Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors-Reference-Cited by-同舟云学术

Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors

Published:2011-01 Issue:1 Volume:185 Page:24-29
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Malouf Gabriel G.¹,Camparo Philippe²,Molinié Vincent³,Dedet Guillaume⁴,Oudard Stéphane⁵,Schleiermacher Gudrun⁶,Theodore Christine⁷,Dutcher Janice⁸,Billemont Bertrand⁹,Bompas Emmanuelle¹⁰,Guillot Aline¹¹,Boccon-Gibod Liliane¹²,Couturier Jérôme¹³,Escudier Bernard¹

Affiliation:

1. Department of Medicine, Institut Gustave Roussy, Villejuif, France

2. Department of Pathology, Hôpital Foch, Suresnes, France

3. Department of Pathology, Hôpital Saint Joseph, Paris, France

4. Department of Public Health, Hôpital Saint Antoine, Paris, France

5. Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France

6. Department of Pediatric Oncology, Institut Curie, Paris, France

7. Department of Medical Oncology, Hôpital Foch, Suresnes, France

8. Montefiore North Division, New York Medical College, Bronx, New York

9. Department of Medical Oncology, Hôpital Cochin, Paris, France

10. Department of Medical Oncology, Centre René Gauducheau, Nantes, France

11. Department of Medical Oncology, Institut de Cancérologie de la Loire, Saint Priest en Jarez, France

12. Department of Pathology, Hôpital d'Enfants Armand Trousseau, Université Paris VI, Paris, France

13. Department of Genetics and INSERM U830, Institut Curie, Paris, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions;Argani,2004

2. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry;Komai;Clin Cancer Res,2009

3. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23);Argani;Oncogene,2003

4. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR;Argani;Am J Surg Pathol,2005

5. Translocation carcinomas of the kidney;Argani;Clin Lab Med,2005

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma;Experimental & Molecular Medicine;2024-08-01

2. A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report;Frontiers in Oncology;2023-10-23

3. Effects of Lipophagy on Atherosclerosis;Central India Journal of Medical Research;2023-05-15

4. Emerging roles of TFE3 in metabolic regulation;Cell Death Discovery;2023-03-11

5. A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma;Genes, Chromosomes and Cancer;2023-02-13